News Industry News Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers May 11, 2017
News Daily News HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer Michael O'Riordan May 10, 2017
News Daily News Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes Shelley Wood May 02, 2017
News Daily News Cardiac Intensive Care Units Face an Ever More Complex Patient Population Caitlin E. Cox April 28, 2017
News Conference News Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial Todd Neale April 07, 2017
Presentation ECHO 2017 Echocardiography in the Management of Patients With Left Ventricular Assist Devices Presenter: Michael H. Picard March 31, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
News Daily News Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research Yael L. Maxwell February 22, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Daily News After a Lull, Cardioband Purchase Represents Latest in Mitral Valve Tech Acquisitions Shelley Wood November 30, 2016
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
Presentation AHA 2016 Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial Presenter: David M Kaye November 15, 2016
News Conference News AHA 2016 Early Vasodilator Therapy Not the Answer for Improving Long-term Outcomes After Acute Decompensated Heart Failure Todd Neale November 13, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016